American Shared Hospital Services · AMEX:AMS
American Shared Hospital Services — Investor Presentation (September 2019)
17 slides from American Shared Hospital Services's investor presentation, September 2019
Slide 1: American Shared Hospital Services
American Shared Hospital Services Making the Best Healthcare Technology Accessible NYSE American: AMS September 2019
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services (including statements regarding the expected continued growth in volume of the MEVI
Slide 3: Overview
Overview American Shared Hospital Services has an over 30-year track record of leasing state-of-the-art medical equipment to hospitals and medical centers in the United States and abroad. Through GK Financing, LLC (GKF), our 81% owned subsidiary, we are the worldwide leader in Gamma Knife unit owner
Slide 4: Investment Highlights
Investment Highlights + Pioneer in single room Proton Beam Radiation Therapy (PBRT) services + World leading supplier of Gamma Knife services + Long-standing alliances with premier cancer centers + Large market opportunities Proton Therapy has low market penetration Advanced radiation therapy device
Slide 5: Respected Management Team With Deep Experience
Respected Management Team With Deep Experience Years of Healthcare MANAGEMENT TEAM Experience Ernest A. Bates, M.D. 30+ Founder, Chairman and CEO Craig K. Tagawa 30+ COO and CFO Ernest R. Bates 10+ V.P., Sales and Business Development Alexis Wallace 10+ Controller NYSE American: AMS 5
Slide 6: Highly Regarded Customers
Highly Regarded Customers* + UC San Francisco Medical Center + Tufts Medical Center: Boston, MA + Methodist Hospital: San Antonio, TX + University of Arkansas for Medical + Johns Hopkins Medical Center: Baltimore, Sciences: Little Rock, AR MD + Merit Health Central: Jackson, MS + Yale-New Haven Hosp
Slide 7: Proven Business Model
Proven Business Model + Structured as an alternative leasing company + Offer Innovative financing features not available from traditional finance companies + Long Term Agreements Typically 10 years + Revenue Sharing or Fee Per Use No minimum volume guarantees ASHS’ RESPONSIBILITIES HOSPITAL’S RESPON
Slide 8: Current Business Status
Current Business Status + Identifying healthcare technology investment opportunities with long term growth potential + In negotiations for 2 additional PBRT installations + Gamma Knife Completed first Icon upgrade + Identifying additional international opportunities NYSE American: AMS 8
Slide 9: Growing Contribution from Proton Therapy
Growing Contribution from Proton Therapy Revenue Summary 2013 – 2018 $ / Millions $25 $20 0.5 0.6 1.1 1.5 0.4 2.1 4.1 0.9 5.0 $15 $10 $5 $0 2013 2014 2015 2016 2017 2018 GKF PBRT IGRT NYSE American: AMS 9
Slide 10: Expansion Opportunities
Expansion Opportunities + Develop single and two room proton beam radiation therapy centers with major hospitals + MR Guided Linac + Community Hospitals + International + Latin America initially NYSE American: AMS 10
Slide 11: Proton Radiation Therapy
Proton Radiation Therapy + Commercial & Profitable: + NOT a NEW Technology Single room proton beam radiation therapy centers + Clinically Advantageous + Significantly reduced + Protons deposit dose at tumor, average cost / treatment versus x-rays passing through the room to $30 - $40M tumor + ASHS p
Slide 12: Photon vs. Proton
Photon vs. Proton Pediatric Medulloblastoma Photon Beam Delivery % Dose Recommended Proton Beam Delivery PBRT Delivers a Full, Even Dose NYSE American: AMS 12
Slide 13: PBRT U.S. Market Opportunity
PBRT U.S. Market Opportunity + Currently only 30 PBRT centers* Current capacity ~90 rooms + 4 PBRT centers under construction or in development* + Only 7% to 14% of projected capacity is currently available for treatment ASHS projected capacity required - 635 – 1,270 rooms** + Each additional treatm
Slide 14: Low Market Penetration
Low Market Penetration PBRT CAPTURE RATE 15% 2 30% 3 Number of radiation therapy patients 1,057,47 1,057,47 annually in the U.S.1 0 0 Percent of radiation therapy patients 15% 30% eligible for PBRT Number of potential PBRT patients 158,600 317,241 in the U.S. Potential PBRT room market* 635 1,270 Cu
Slide 15: Gamma Knife Radiosurgery Equipment
Gamma Knife Radiosurgery Equipment + World’s leading supplier U.S. market share ~13% + Gold standard equipment for cranial radiosurgery Non-invasive alternative to surgery for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain) + Typically improves patien
Slide 16: Key Takeaways
Key Takeaways + Pioneer in single room Proton Beam Radiation Therapy (PBRT) services + World leading supplier of Gamma Knife services + Long-standing alliances with premier cancer centers + Large market opportunities Proton Therapy has low market penetration Advanced radiation therapy devices + Prov
Slide 17: Thank You!
American Shared Hospital Services Making the Best Healthcare Technology Accessible For Further Information Contact: Thank You! Craig Tagawa COO and CFO [email protected] (415) 788-5300 NYSE American: AMS www.ashs.com 17
American Shared Hospital Services — Investor Presentation (September 2019) on 6ix